• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者的严重肢体缺血:与年轻患者相比的治疗结果

Critical Limb Ischaemia in Octogenarians: Treatment Outcomes Compared With Younger Patients.

作者信息

Ormaechevarria Amaia, Vega de Céniga Melina, Blanco June, Yáñez Laura, Fernández June, Estallo Luis

机构信息

Department of Angiology and Vascular Surgery, Galdakao-Usansolo University Hospital, Bizkaia, Spain.

出版信息

EJVES Vasc Forum. 2024 Jan 3;61:36-42. doi: 10.1016/j.ejvsvf.2023.12.003. eCollection 2024.

DOI:10.1016/j.ejvsvf.2023.12.003
PMID:38312331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10837062/
Abstract

OBJECTIVE

A growing proportion of patients with chronic limb threatening ischaemia (CLTI) are elderly, the most challenging for management decisions. The aim was to study the patient profile and outcome of CLTI in octogenarian patients, comparing them with younger patients.

METHODS

Retrospective cohort of consecutive patients hospitalised for CLTI with infrainguinal disease in a Spanish centre (2013-2020). Data on age, comorbidity, anatomical characteristics, and treatment were gathered. Patients were stratified according to age (<80 and ≥80 years). The primary outcomes were overall survival and limb salvage (LS), analysed using Kaplan-Meier and Cox regression.

RESULTS

: A total of 512 patients were enrolled: 305 were <80 years old with mean age 69.7 ± standard deviation (SD) 8.2 years, and 207 were ≥80 years old with mean age 85.3 ± SD 3.6 years. Smoking and diabetes mellitus were more frequent in younger patients (78.0% . 45.4%, < .001; 68.5% 59.5%,  = .037 respectively). Older patients had a higher prevalence of heart and kidney disease (70.5% vs. 57.0%,  = .002; 39.6% 24.3%, < .001, respectively). The arterial disease was femoropopliteal or tibial in 68.9% and 31.1% in patients <80 years and 58.9% and 41.1% in patients ≥80 years ( = .021). In younger patients, conservative treatment was indicated in 18.0%, endovascular treatment (ET) in 41.6%, and open or hybrid surgery (OS) in 40.3%; in patients ≥80 years these were 36.9%, 37.4%, and 25.7%, respectively ( <. 001). Mean follow up was 23.3 ± SD 17.4 months. One and two year overall survival was 85.4% and 73.0% in younger patients and 64.1% and 51.3% in patients ≥80 years ( < .001). LS was 83.7% and 79% at the same times in younger patients and 75.3% and 72.1% in older ones ( = .045). In younger patients ET led to worse LS than OS ( = .005) but not in older patients ( = .29).

CONCLUSION

Patients ≥80 years with CLTI have higher comorbidity and lower life expectancy and receive conservative treatment more frequently than younger patients. ET and OS are associated with similar survival and LS in these older patients.

摘要

目的

在慢性肢体威胁性缺血(CLTI)患者中,老年患者的比例日益增加,这给治疗决策带来了极大挑战。本研究旨在探讨八旬CLTI患者的特征及预后,并与年轻患者进行比较。

方法

对西班牙某中心(2013 - 2020年)因CLTI伴股腘以下病变而连续住院的患者进行回顾性队列研究。收集患者的年龄、合并症、解剖特征及治疗等数据。根据年龄将患者分为两组(<80岁和≥80岁)。主要结局指标为总生存率和肢体挽救率(LS),采用Kaplan-Meier法和Cox回归分析。

结果

共纳入512例患者:305例年龄<80岁,平均年龄69.7±标准差(SD)8.2岁;207例年龄≥80岁,平均年龄85.3±SD 3.6岁。年轻患者中吸烟和糖尿病更为常见(分别为78.0%对45.4%,P<0.001;68.5%对59.5%,P = 0.037)。老年患者中心脏病和肾病的患病率更高(分别为70.5%对57.0%,P = 0.002;39.6%对24.3%,P<0.001)。年龄<80岁患者中,股腘动脉病变和胫动脉病变分别占68.9%和31.1%;年龄≥80岁患者中,上述比例分别为58.9%和41.1%(P = 0.021)。年轻患者中,18.0%接受保守治疗,41.6%接受血管内治疗(ET),40.3%接受开放或杂交手术(OS);年龄≥80岁患者中,上述比例分别为36.9%、37.4%和25.7%(P<0.001)。平均随访时间为23.3±SD 17.4个月。年龄<80岁患者1年和2年总生存率分别为85.4%和73.0%,年龄≥80岁患者分别为64.1%和51.3%(P<0.001)。同期年轻患者LS分别为83.7%和79%,老年患者分别为75.3%和72.1%(P = 0.045)。在年轻患者中,ET导致的LS比OS差(P = 0.005),但在老年患者中并非如此(P = 0.29)。

结论

年龄≥80岁的CLTI患者合并症更多,预期寿命更低,且比年轻患者更常接受保守治疗。在这些老年患者中,ET和OS的生存率和LS相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/84ad120c1fa7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/d630dbeb437c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/81af51a812e9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/84ad120c1fa7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/d630dbeb437c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/81af51a812e9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e177/10837062/84ad120c1fa7/gr3.jpg

相似文献

1
Critical Limb Ischaemia in Octogenarians: Treatment Outcomes Compared With Younger Patients.老年患者的严重肢体缺血:与年轻患者相比的治疗结果
EJVES Vasc Forum. 2024 Jan 3;61:36-42. doi: 10.1016/j.ejvsvf.2023.12.003. eCollection 2024.
2
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术后的生存预测。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S120-S134.e3. doi: 10.1016/j.ejvs.2019.04.009. Epub 2019 May 28.
3
Real Life Outcomes of Infrapopliteal Endovascular and Surgical Bypass Intervention for Chronic Limb Threatening Ischaemia in GLASS Stages II and III.GLASS 分期 II 和 III 级慢性肢体缺血性威胁患者的腘动脉以下腔内血管和旁路手术干预的实际临床转归。
Eur J Vasc Endovasc Surg. 2022 Jul;64(1):41-48. doi: 10.1016/j.ejvs.2022.04.036. Epub 2022 May 7.
4
Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.比较长段股腘动脉病变的慢性肢体缺血威胁患者腔内治疗与旁路移植手术的长期疗效。
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):258-269. doi: 10.1016/j.ejvs.2020.11.009. Epub 2020 Dec 15.
5
Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).当代(2009-2014 年)股腘旁路手术治疗慢性肢体威胁性缺血的临床结果劣于英国旁路与血管成形术治疗严重肢体缺血(BASIL)试验(1999-2004 年)报道的结果。
J Vasc Surg. 2019 Jun;69(6):1840-1847. doi: 10.1016/j.jvs.2018.08.197. Epub 2019 Mar 7.
6
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术的生存预测。
J Vasc Surg. 2019 Jun;69(6S):137S-151S.e3. doi: 10.1016/j.jvs.2018.08.169. Epub 2018 Nov 26.
7
Limb salvage in octogenarians with critical limb ischemia after lower extremity bypass surgery.高龄患者下肢旁路手术后出现严重肢体缺血的保肢治疗。
J Vasc Surg. 2023 Jul;78(1):217-222. doi: 10.1016/j.jvs.2023.02.022. Epub 2023 Mar 11.
8
Disease Specific Health Related Quality of Life in Patients With Chronic Limb Threatening Ischaemia Undergoing Revascularisation of Femoropopliteal Lesions.慢性肢体严重缺血患者行股腘病变血运重建后疾病特异性健康相关生活质量
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):245-251. doi: 10.1016/j.ejvs.2023.05.014. Epub 2023 May 16.
9
Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在慢性肢体威胁性缺血中的生存改善。
J Vasc Surg. 2020 Dec;72(6):2130-2138. doi: 10.1016/j.jvs.2020.02.041. Epub 2020 Apr 8.
10
Impact of Statins on Survival and Limb Salvage in Patients Undergoing Peripheral Endovascular Intervention for Chronic Limb-Threatening Ischemia.他汀类药物对外周血管腔内介入治疗慢性肢体威胁性缺血患者的生存和保肢的影响。
Ann Vasc Surg. 2023 Apr;91:20-27. doi: 10.1016/j.avsg.2022.11.010. Epub 2022 Dec 9.

本文引用的文献

1
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.对于需要进行 below-the-knee(小腿)、伴或不伴额外更近端 below-inguinal(腹股沟下)血运重建以恢复肢体灌注的慢性肢体威胁性缺血患者,静脉旁路优先与最佳血管内治疗优先再血管化策略的比较(BASIL-2):一项开放标签、随机、多中心、3 期试验。
Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25.
2
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的手术或血管内治疗。
N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7.
3
Characteristics and outcomes of octogenarians with revascularized critical limb ischemia: Impact of altered cardiac function for early mortality.八旬老人血运重建治疗的临界肢体缺血的特征和结果:改变心脏功能对早期死亡率的影响。
J Med Vasc. 2021 Oct-Dec;46(5-6):224-231. doi: 10.1016/j.jdmv.2021.10.003. Epub 2021 Nov 5.
4
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
5
One-Year Results of First-Line Treatment Strategies in Patients With Critical Limb Ischemia (CRITISCH Registry).伴有严重肢体缺血患者一线治疗策略的一年结果(CRITISCH 注册研究)。
J Endovasc Ther. 2018 Jun;25(3):320-329. doi: 10.1177/1526602818771383. Epub 2018 Apr 26.
6
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.下肢慢性肢体威胁性缺血血运重建结局的系统评价和荟萃分析。
J Vasc Surg. 2018 Aug;68(2):624-633. doi: 10.1016/j.jvs.2018.01.066. Epub 2018 May 24.
7
Quality of Life and Mortality after Endovascular, Surgical, or Conservative Treatment of Elderly Patients Suffering from Critical Limb Ischemia.老年严重肢体缺血患者接受血管内治疗、手术治疗或保守治疗后的生活质量与死亡率
Ann Vasc Surg. 2018 Aug;51:95-105. doi: 10.1016/j.avsg.2018.02.044. Epub 2018 Jun 12.
8
Life Expectancy and Outcome of Different Treatment Strategies for Critical Limb Ischemia in the Elderly Patients.老年患者严重肢体缺血不同治疗策略的预期寿命及结果
Ann Vasc Surg. 2018 Jan;46:241-248. doi: 10.1016/j.avsg.2017.06.141. Epub 2017 Jul 6.
9
Outcomes After Endovascular Revascularization in Octogenarians and Non-Octogenarians With Critical Limb Ischemia.八旬及非八旬严重肢体缺血患者血管内血运重建后的结局
J Endovasc Ther. 2017 Aug 1;24(4):471-477. doi: 10.1177/1526602817711424. Epub 2017 Jun 5.
10
Conservative Treatment in Selected Patients with Severe Critical Limb Ischemia.部分严重肢体缺血患者的保守治疗
World J Surg. 2015 Aug;39(8):2090-5. doi: 10.1007/s00268-015-3069-6.